VJHemOnc is committed to improving our service to you

EHA 2019 | First-line treatment of SAA: towards a new standard of care?

VJHemOnc is committed to improving our service to you

Regis Peffault de Latour

Regis Peffault de Latour, MD, PhD, Saint Louis Hospital, Paris, France, discusses novel combination therapies for the treatment of severe aplastic anemia (SAA). This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter